It has been postulated that changes in expression and phosphorylation of the insulin signaling intermediates precedes the development of overt IR and glucose intolerance [92], providing a molecular signature associated with early stages, or pre-clinical status, of disease progression [93]. Here, INS is linked to Glucose intolerance.